Broker│ Rating│ Target Price (HKD)JPMorgan│Overweight│90Morgan Stanley│Overweight│89Citi│Buy│82Goldman Sachs│Buy│75CLSA│Outperform│71->74BofA Securities│Buy│74Broker | OpinionJPMorgan | High-quality growth and solid core profitability alleviated key market concernsMorgan Stanley | 1Q26 results were solidCiti | Management expected double-digit growth in 2026 new business valueGoldman Sachs | 1Q26 earnings beat expectation, with solid operating profit growth and strong growth in new business value for life insuranceCLSA | 1Q26 net profit's decline was smaller than industry averageBofA Securities | 1Q26 earnings slightly beat forecastRelated News CICC: Short-term Capital Overhang to Reverse; Expects Valuation Recovery in Mainland Insurers, Recommends CPIC (02601.HK), PING AN (02318.HK) etc.
AASTOCKS Financial News